U
NEO icon

UBS’s NeoGenomics NEO Stock Holding History

UBS’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-800
Closed -$3K – 10604
2014
Q2 		$3K Sell
800
-2,200
-73% -$7.31K ﹤0.01% 9836
2014
Q1 		$10K Hold
3,000
– – ﹤0.01% 8903
2013
Q4 		$11K Buy
+3,000
New +$10.4K ﹤0.01% 8883

Other funds holding NEO

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
GP
Grow Partners San Diego, California $4.81M AUM 7.86% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

UBS's NEO Position: Q3 2014 in Review

UBS reduced its NeoGenomics (NEO) stake by 92% in Q3 2014, selling an estimated $7.67K and leaving 125 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #10173.

UBS first reported a position in NEO in Q2 2013 and has held it in 6 quarters since. The position peaked at $48K in Q3 2013. 88 funds tracked by Wall St. Rank hold NEO as of Q3 2014.

  • UBS held 125 shares of NeoGenomics worth $1K as of Q3 2014.
  • UBS sold 1,493 NeoGenomics shares in Q3 2014, an estimated $7.67K.
  • NeoGenomics made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10173 holding.
  • UBS first reported a position in NeoGenomics in Q2 2013 and has held it in 6 quarters since.
  • UBS's NeoGenomics position peaked at $48K in Q3 2013.
  • 88 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.